New Efforts to Improve Cancer Treatment Decisions with Better Data
Measuring how long a cancer treatment extends life (overall survival, or OS) is the best way to judge its effectiveness. […]
FDA Gives Fast-Track Status to New Lung Cancer Treatment
The US Food and Drug Administration (FDA) has given special recognition to a new experimental drug called izalontamab brengitecan (iza-bren).
Pharmaceutical News
Gilead’s Kite to Buy Interius BioTherapeutics for $350 Million to Advance Next-Gen Cancer Treatments
Gilead’s Kite Pharma has agreed to purchase Interius BioTherapeutics for $350 million. This deal will help Kite expand its work
Pharmaceutical News
Eli Lilly’s Neuroscience Leader Anne White to Retire After 30 Years
Anne White, the Executive Vice President and President of Lilly Neuroscience at Eli Lilly and Company, will retire at the
Eli Lilly Seeks New Neuroscience Leader as Longtime Executive Anne White Retires
Eli Lilly is looking for a new leader for its neuroscience division after announcing that Anne White, the current head,
New Blood Test Could Replace Tissue Biopsies for Cancer Patients
In this project, ANGLE’s research team will use the Parsortix system to collect cancer cells from the blood of cancer
Pharmaceutical News
Johnson & Johnson Invests $2 Billion to Expand US Drug Manufacturing with Fujifilm
Johnson & Johnson (J&J) has made a major move to strengthen its US manufacturing operations by signing a $2 billion,
Study Shows How Better Screening Helps People with Substance Use Disorder Fight Infections
The US Centers for Disease Control and Prevention (CDC) reports that about one in six Americans struggles with substance use
AstraZeneca’s Breakthrough in Lung Cancer Treatment: Targeting the EGFR Mutation
AstraZeneca’s journey in lung cancer treatment began in 2003 with a drug called Iressa, which targeted a specific gene mutation
Pharmaceutical News
ICH Seeks Public Input on New Guidelines for Drug Impurities from Leachables
The International Council for Harmonisation (ICH) has opened a public consultation on its draft guidelines for managing drug impurities caused